Targefrin presents a peptide-derived framework designed to interrogate receptor-recognition motifs and epitope architecture. Hydrophobic and charged residues cooperate to define binding surfaces and solubility. Researchers monitor its conformational states in aqueous and membrane-like environments. Applications include ligand-screening panels, peptide-optimization campaigns, and structure-function investigations.
CAT No: R2848
Synonyms/Alias:Targefrin; CHEMBL5192123; EphA2 degrader 27; GLXC-26516; HY-P3717; BDBM50588608; 3031514-44-7; (Piperazin-1-yl)Ac-(4-NH2)Phe-Leu-Ala-(4-(2-CF3)phenyl)Phe-Pro-Asp-Ala-Chg-Pro-Phe-Arg-Pro-NH2
Targefrin is a synthetic carbohydrate-based compound that has garnered significant attention in biochemical research due to its unique molecular architecture and functional versatility. As a glycomimetic molecule, Targefrin is engineered to mimic specific carbohydrate structures found on cell surfaces, enabling precise modulation of biological interactions. Its robust stability and affinity for select lectins and receptors make it an invaluable tool for exploring complex carbohydrate-mediated signaling pathways. Researchers appreciate Targefrin for its solubility in aqueous environments and compatibility with a range of experimental systems, from in vitro cell culture assays to advanced analytical platforms. By offering a reliable means to probe carbohydrate recognition events, Targefrin supports the elucidation of key mechanisms underlying cellular communication, pathogen-host interactions, and immune responses.
Glycobiology Research: Targefrin serves as a powerful probe in glycobiology, where understanding the roles of carbohydrates in biological processes is paramount. Scientists utilize it to dissect the intricacies of glycan-lectin interactions, which are central to cell signaling, adhesion, and immune modulation. By acting as a competitive inhibitor or surrogate ligand, Targefrin enables the selective blocking or stimulation of carbohydrate-binding proteins, thereby unraveling the functional consequences of glycan recognition in both normal and pathological states. Its defined structure allows for reproducible experimentation, facilitating the mapping of carbohydrate recognition domains and the identification of novel glycan-dependent pathways.
Pathogen-Host Interaction Studies: In the field of infectious disease research, Targefrin is instrumental for investigating how pathogens exploit host cell surface carbohydrates to initiate infection. Many viruses, bacteria, and parasites rely on specific glycan motifs for attachment and entry into host cells. By mimicking these motifs, Targefrin can be used to competitively inhibit pathogen binding, helping to delineate the molecular determinants of host specificity and virulence. This approach aids in the identification of critical carbohydrate-mediated steps in the infectious process, providing a foundation for the development of targeted intervention strategies.
Cell Adhesion and Migration Assays: The compound is widely adopted in studies focused on cell adhesion and migration, processes that are heavily influenced by carbohydrate-protein interactions. Targefrin can be incorporated into in vitro assays to investigate how alterations in glycan presentation affect cellular behavior, such as movement, aggregation, or tissue invasion. By selectively engaging or blocking adhesion molecules, it helps clarify the roles of specific glycans in developmental biology, cancer metastasis, and tissue regeneration. These insights are pivotal for understanding how cells navigate complex microenvironments and respond to external cues.
Immunological Investigations: Targefrin's utility extends to immunology, where it is employed to study the modulation of immune cell activity by carbohydrate structures. Many immune receptors recognize distinct glycans as part of pathogen recognition or self/non-self discrimination. By serving as a glycan mimic, Targefrin can be used to stimulate or inhibit immune responses in controlled experimental settings. This capability is particularly valuable for dissecting the molecular basis of immune recognition, tolerance, and activation, contributing to the broader understanding of immune system regulation.
Analytical and Diagnostic Tool Development: The distinctive binding properties of Targefrin make it an attractive candidate for the development of analytical and diagnostic tools. Researchers leverage its specificity to design biosensors and affinity columns for the detection and quantification of carbohydrate-binding proteins in complex biological samples. In glycomics and proteomics workflows, Targefrin-based reagents streamline the isolation and characterization of lectins, antibodies, or other glycan-interacting molecules. These applications support high-throughput analysis and foster innovations in biomarker discovery, quality control, and fundamental research.
Synthetic carbohydrate compounds like Targefrin continue to advance the frontiers of molecular biology, offering precise and customizable platforms for probing the myriad roles of glycans in health and disease. As research in glycobiology, infectious disease, cell biology, immunology, and analytical science progresses, Targefrin remains a cornerstone reagent, enabling scientists to unravel the complexities of carbohydrate-mediated phenomena and accelerate the pace of discovery across diverse disciplines.
1. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
4. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More